John Duncan Higgons's Net Worth
$27.9 Million
Who is John Duncan Higgons?
John Duncan Higgons has an estimated net worth of $27.9 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Jounce Therapeutics, Inc..
SEC CIK
John Duncan Higgons's CIK is 0001581954
Past Insider Trading and Trends
2015 was John Duncan Higgons's most active year for acquiring shares with 19 total transactions. John Duncan Higgons's most active month to acquire stocks was the month of May. 2014 was John Duncan Higgons's most active year for disposing of shares, totalling 34 transactions. John Duncan Higgons's most active month to dispose stocks was the month of February. 2016 saw John Duncan Higgons paying a total of $195,925.16 for 58,999 shares, this is the most they've acquired in one year. In 2015 John Duncan Higgons cashed out on 402,000 shares for a total of $15,214,986.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $43.28
Chief Operating OfficerJohn Duncan Higgons owns 120,834 units of Common Stock which is worth $5,229,695.52.acquired a total of 400,744 shares in AGIOS PHARMACEUTICALS INC at a cost of $315,211.26, John also disposed a total of 401,000 shares of AGIOS PHARMACEUTICALS INC equalling to $23,019,194.63.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.41% | 59K |
$3.32 | $195,925.16 | 120.83K |
Jan 4
| |||
Form 4
| -24.44% | -20.00K |
$50.09 | -$1,001,800.00 | 61.84K |
Scheduled
|
Dec 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
$31.30 | -$1,208,435.56 | 81.83K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$35.68 | -$1,414,556.20 | 81.83K |
Scheduled
|
Oct 15
| ||
Form 4
| -46.10% | -70.00K |
—
|
—
| 81.83K |
Oct 7
| |||
Form 4
| +7.05% | 10K |
$0.30 | $3,025.00 | 151.84K |
Sep 30
| |||
Form 4
|
—
|
0
|
$45.71 | -$1,816,150.00 | 141.84K |
Scheduled
|
Sep 15
| ||
Form 4
| +7.59% | 10K |
$0.30 | $3,025.00 | 141.84K |
Aug 20
| |||
Form 4
|
—
|
0
|
$46.27 | -$1,838,750.00 | 131.84K |
Scheduled
|
Aug 17
| ||
Form 4
| +8.21% | 10K |
$0.30 | $3,025.00 | 131.84K |
Aug 6
| |||
Form 4
|
—
|
0
|
$57.16 | -$2,274,350.00 | 121.83K |
Scheduled
|
Jul 16
| ||
Form 4
| -5.43% | -7.00K |
$105.23 | -$736,610.00 | 121.83K |
Scheduled
|
Jun 15
| ||
Form 4
| +30.35% | 30K |
$0.30 | $9,075.00 | 128.84K |
Jun 10 - Jun 12
| |||
Form 4
| -6.98% | -7.42K |
$112.89 | -$837,305.13 | 98.83K |
Scheduled
|
May 15
| ||
Form 4
| -5.83% | -6.58K |
$99.54 | -$655,271.82 | 106.25K |
Scheduled
|
Apr 15
| ||
Form 4
| -5.84% | -7.00K |
$106.24 | -$743,680.00 | 112.83K |
Scheduled
|
Mar 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -9.10% | -12.00K |
$110.08 | -$1,320,960.00 | 119.83K |
Scheduled
|
Jan 2
| ||
Form 4
| -9.10% | -12.00K |
$110.08 | -$1,320,960.00 | 119.83K |
Scheduled
|
Jan 2
| ||
Form 4
| -8.34% | -12.00K |
$97.03 | -$1,164,360.00 | 131.84K |
Scheduled
|
Dec 1
| ||
Form 4
| -8.29% | -13.00K |
$81.71 | -$1,062,230.00 | 143.84K |
Scheduled
|
Nov 3
| ||
Form 4
| -7.65% | -13.00K |
$60.07 | -$780,910.00 | 156.84K |
Scheduled
|
Oct 1
| ||
Form 4
| -3.55% | -6.25K |
$23.30 | -$599,859.64 | 169.84K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$22.67 | -$223,737.50 | 176.09K |
Scheduled
|
Aug 26
| ||
Form 4
|
—
|
0
|
$19.70 | -$271,512.50 | 176.09K |
Scheduled
|
Aug 1
| ||
Form 4
| -6.38% | -12.00K |
$46.52 | -$558,240.00 | 176.09K |
Scheduled
|
Jul 1
| ||
Form 4
| -2.59% | -5.00K |
$45.27 | -$226,350.00 | 188.09K |
Scheduled
|
Jun 13
| ||
Form 4
| -3.50% | -7.00K |
$34.47 | -$241,308.00 | 193.09K |
Scheduled
|
Jun 2 - Jun 3
| ||
Form 4
| -2.44% | -5.00K |
$45.73 | -$228,650.00 | 200.09K |
Scheduled
|
May 6
| ||
Form 4
| -1.91% | -4.00K |
$21.35 | -$295,822.50 | 205.09K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$22.74 | -$134,602.50 | 209.09K |
Scheduled
|
Apr 4 - Apr 7
| ||
Form 4
|
—
|
0
|
$19.19 | -$453,330.00 | 209.09K |
Scheduled
|
Apr 1
| ||
Form 4
| +61.97% | 80K |
$0.30 | $24,200.00 | 209.09K |
Mar 19
| |||
Form 4
| +18.33% | 20K |
$0.30 | $6,050.00 | 129.09K |
Mar 10
| |||
Form 4
|
—
|
0
|
$20.85 | -$602,128.42 | 109.09K |
Scheduled
|
Mar 5 - Mar 7
| ||
Form 4
|
—
|
0
|
$15.08 | -$236,412.00 | 109.09K |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$17.68 | -$81,819.16 | 109.09K |
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
$13.14 | -$205,308.00 | 109.09K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$17.51 | -$412,899.60 | 109.09K |
Scheduled
|
Jan 21
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
InvestorJohn Duncan Higgons owns 9,713 units of Common Stock. In the year 2017 John Duncan Higgons filed a total of 13 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -2.02% | -200.00 |
$10.00 | -$2,000.00 | 9.71K |
Scheduled
|
Apr 15
| ||
Form 4
| -1.98% | -200.00 |
$12.80 | -$2,560.00 | 9.91K |
Scheduled
|
Mar 15
| ||
Form 4
| -1.94% | -200.00 |
$11.78 | -$2,356.00 | 10.11K |
Scheduled
|
Feb 16
| ||
Form 4
| -14.15% | -1.70K |
$11.90 | -$20,222.00 | 10.31K |
Scheduled
|
Jan 20 - Jan 21
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
| -11.10% | -1.50K |
$8.11 | -$12,165.00 | 12.01K |
Scheduled
|
Jan 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
| +32.96% | 6.7K |
$16.00 | $107,200.00 | 27.02K |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||